207 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Organisation structure National Health Care Institute

Publication | 06-06-2018

Room for improvement analysis: claudication intermittent - Zinnige Zorg

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be...

Report | 30-05-2018

Flash Glucose Monitoring (FGM)

In this report Zorginstituut Nederland (National Health Care Institute) assesses whether Flash Glucose Monitoring (FGM)...

Report | 30-04-2018

Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

Zorginstituut Nederland has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report concludes...

Report | 17-04-2018

Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the...

Report | 01-03-2018

Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

Zorginstituut Nederland issued package advice on the medicinal product evolocumab (Repatha®) for the treatment of...

Report | 18-01-2018

Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL...

Report | 04-01-2018

Room for improvement analysis: Chest pain (Suspected) Stable Angina Pectoris - Zinnige Zorg

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be...

Report | 17-12-2017

Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not...

Report | 20-10-2017

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017